Faisal Ahmad, MD
Internal Medicine · Lake Mary, FLNPI 1699723619
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,847 of the $4,201 with a category attached, or 91.6%. Johnson & Johnson accounts for 91.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $3,900, more than ten times the $175 reported in 2019.
Across 20 payments — averaging $210.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$4K
- Medtronic$87
- GSK$73
- Smith+Nephew$67
- Acclarent, Inc$67
- Boston Scientific$21
- plus $38 from 2 others
What the payments were for
- Travel & lodging$3,84792%
- Food & beverage$3538%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $3,847 |
| Medtronic | 1 | $87 |
| GSK | 4 | $73 |
| Smith+Nephew | 1 | $67 |
| Acclarent, Inc | 1 | $67 |
| Boston Scientific | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $18 |
How this compares
$4,201 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 57 | $29,790 |
| JardianceEmpagliflozin | 16 | $9,053 |
| BrilintaTicagrelor | 15 | $6,405 |
| EntrestoSacubitril/Valsartan | 13 | $6,258 |
| Linezolid | 19 | $1,026 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,023 |
| Cefdinir | 97 | $979 |
| CefuroximeCefuroxime Axetil | 60 | $690 |
| Nitroglycerin | 66 | $573 |
| Pantoprazole Sodium | 94 | $571 |
| Metoprolol Succinate | 81 | $529 |
| Doxycycline Hyclate | 111 | $502 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 64 | $435 |
| ClopidogrelClopidogrel Bisulfate | 65 | $413 |
| Prednisone | 163 | $405 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Lake Mary
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.